Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Pfizer Vaccine
Covid
Moderna Vaccine
Coronavirus Vaccine
Topics

Advertisement

Pfizer Vaccine

Share

Top Latest Popular

⚽ PREMIER DEAL! Follow the action with NewsNow Essentials at just £2.99/m!

⚽ PREMIER DEAL! Follow the action with NewsNow Essentials at just £2.99 a month!

Pfizer, Moderna Covid vaccines 70% to 76% effective against severe illness in kids in 2022, data suggest Center for Infectious Disease Research and Policy 19:27 Tue, 19 May

Center for Infectious Disease Research and Policy 19:27 Tue, 19 May

Pfizer Children and Coronavirus

Coronavirus Vaccine

Pfizer wins Singapore trademark dispute with Merck over vaccine brand The Straits Times 09:07 Fri, 22 May

The Straits Times 09:07 Fri, 22 May

Pfizer Merck and Co

Can Pfizer's dividend survive the patent cliff? This $10.5 Billion cancer bet could hold the answer. The Motley Fool 3d

The Motley Fool 3d

Advertisement

Advertisement

Pfizer reports positive Phase II data for PF-07872412 in infants Clinical Trials Arena 11:35 Thu, 21 May

Clinical Trials Arena 11:35 Thu, 21 May

Lilly’s $3.8B vaccine deal caps a $25B, 2026 push to preempt disease R&D World 23:50 Tue, 26 May

R&D World 23:50 Tue, 26 May

Moderna Vaccine FDA

Meet the biotech stock that's trouncing Lilly, Merck, and Pfizer in 2026 The Motley Fool 7d

The Motley Fool 7d

Pfizer Merck and Co

Moderna Vaccine

Advertisement

Advertisement

Latest

Saturday

Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer. The Motley Fool 18:46 Sat, 06 Jun

Wednesday

Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 The Motley Fool 07:51 Wed, 03 Jun

In the last month

Lack Of Indemnity Liability Doomed Vax IP Case, Judge Says Law360 22:20 Tue, 02 Jun

Climate Change Is Driving a Tick Boom The Energy Mix 17:34 Tue, 02 Jun

Lilly’s $3.8B vaccine deal caps a $25B, 2026 push to preempt disease R&D World 23:50 Tue, 26 May

Pfizer wins Singapore trademark dispute with Merck over vaccine brand The Straits Times 09:07 Fri, 22 May

Pfizer reports positive Phase II data for PF-07872412 in infants Clinical Trials Arena 11:35 Thu, 21 May

Pfizer takes 25-valent Prevnar follow-up into phase 3 pharmaphorum 18:57 Wed, 20 May

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Phase 2 Data RTT News 12:32 Wed, 20 May

Pfizer Advances Pneumonia Shot After Positive Study in Children Bloomberg Law 10:24 Wed, 20 May

Advertisement

Advertisement

Advertisement

Don't miss out! Get the day's top headlines delivered to your inbox

Stay informed. Sign up for a FREE NewsNow account and get our email alert of the day's top stories from the UK and around the world.

Already have an account?

By clicking 'Create Account and Subscribe' you agree to us creating an account for you and subscribing you to our newsletter in accordance with our Privacy Policy and Legal Notice.

Emails, which may be sent daily or less frequently, may include marketing elements. We will not share your email address with any third parties. You can unsubscribe whenever you want.

Advertisement

Advertisement

About our Pfizer-BioNTech Covid-19 Vaccine news

Latest news on the Pfizer-BioNTech Covid-19 vaccine, a mRNA vaccine developed by Pfizer in collaboration with BioNTech.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

- Back to Global Health Coronavirus (Covid-19)
  - Coronavirus Vaccine
  - Moderna Vaccine
  - Pfizer Vaccine
  - Long Covid Long Covid
  - Children and Coronavirus